Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by NOVO NORDISK INC
FDA Drug Application 019991 by NOVO NORDISK INC
Application Number
019991
Application Type
New Drug Application
Sponsor Applicant
NOVO NORDISK INC
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New manufacturer
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
6/25/1991
N
AP
0
10/7/1991
SCS
AP
0
3/13/1992
SCS
AP
0
3/26/1993
SCS
AP
0
3/26/1993
SLR
AP
0
1/7/1994
SLR
AP
0
4/26/1994
SCS
AP
0
5/23/1994
SCS
AP
0
5/31/1994
SCS
AP
0
6/16/1994
SCS
AP
0
6/23/1994
SCS
AP
0
6/23/1994
SCP
AP
0
1/3/1994
SLR
AP
0
1/4/1994
SLR
AP
0
5/22/1995
SCS
AP
0
1/28/1997
SCS
AP
0
6/13/1996
SCM
AP
0
4/10/1997
SLR
AP
0
1/2/1997
SCS
AP
0
4/16/1997
SLR
4308
021
http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/019991ap.pdf
4/16/1997
AP
0
6/20/1997
SCP
AP
0
8/4/1997
SCS
AP
0
7/24/1998
SCS
AP
0
5/12/1999
SCS
AP
0
10/18/1999
SCM
AP
0
3/16/2000
SCP
AP
0
4/10/2000
SCS
AP
0
6/15/2000
SLR
AP
0
2/21/2001
SCS
AP
0
12/10/2001
SLR
5339
031
http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/19991s31lbl.pdf
4/17/2003
AP
0
3/11/2002
SLR
3028
032
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/19938s30ltr.pdf
3/11/2002
AP
0
3/11/2002
SLR
3029
032
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/19-938S30lbl.pdf
3/11/2002
AP
0
12/13/2000
SCS
AP
0
1/9/2001
SCS
AP
0
4/11/2002
SCP
3018
035
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/19959s34ltr.pdf
4/11/2002
AP
0
4/11/2002
SCP
3019
035
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/19938s32lbl.pdf
4/11/2002
AP
0
4/15/2002
SCP
3016
036
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/19938s33ltr.pdf
4/15/2002
AP
0
4/15/2002
SCP
3017
036
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/19938s33lbl.pdf
4/15/2002
AP
0
12/19/2001
SCP
5340
037
http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/19991s37lbl.pdf
4/17/2003
AP
0
1/10/2002
SCS
AP
0
6/19/2002
SCM
AP
0
6/15/2009
SLR
22775
067
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/019938s063,019959s066,019991s067ltr.pdf
6/18/2009
AP
0
6/15/2009
SLR
22794
067
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019938s063,019959s066,019991s067lbl.pdf
6/22/2009
AP
0
7/17/2009
SCS
23051
068
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019938s064,019959s067,019991s068,020986s055lbl.pdf
7/23/2009
AP
0
7/17/2009
SCS
23084
068
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/019938s064,019959s067,019991s068,020986s055ltr.pdf
7/24/2009
AP
0
6/25/2010
SCM
25845
070
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/019938s067,s069,019959s069,s071,019991s070,072,020986s058,s060ltr.pdf
6/29/2010
AP
0
12/27/2010
SLR
27448
071
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/019938s068_019959s070_019991s071ltr.pdf
1/4/2011
AP
0
6/25/2010
SLR
25846
072
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/019938s067,s069,019959s069,s071,019991s070,072,020986s058,s060ltr.pdf
6/29/2010
AP
0
3/9/2013
SLR
35411
074
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/019991Orig1s074ltr.pdf
3/12/2013
AP
0
3/9/2013
SLR
35434
074
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019991s074lbl.pdf
3/12/2013
AP
0
1/8/2016
SLR
44948
077
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/019991Orig1s077ltr.pdf
1/11/2016
AP
0
1/8/2016
SLR
44963
077
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019991s077lbl.pdf
1/12/2016
Back to FDA Applications sponsored by NOVO NORDISK INC